Blog

Pharmaceutical Patents in South America: Registering Patents in Brazil is Going to be Easierip articles
25 May 2018

Pharmaceutical Patents in South America: Registering Patents in Brazil is Going to be Easier

by Moeller IP Advisors Brazil is one of the biggest pharmaceutical markets in the world. IMS Health -a pharmaceutical consulting and information company- estimated that the Brazilian market will achieve around 40 billions of US dollars in 2017, in pharmaceutical sales. From 2007 to 2011, the market grew an astounding 82%, according to a report […]

Patent Linkage System in Chileip articles
24 May 2018

The Patent Linkage System in Chile

By Moeller IP Advisors Research and Development of pharmaceutical products is an extremely capital intensive activity. It takes an average 10 of years for a new drug to be developed, tested and commercialized; only one out of five thousand drugs are approved for human testing and among these, only one out of five makes it […]

Patentability of Embryonic Stem Cells in Mexicoip articles
23 May 2018

Patentability of Embryonic Stem Cells in Mexico

By Moeller IP Advisors Stem cells have the potential to treat a wide range of diseases and constitute a key research tool in the development of novel therapies and personalised medicine. There are two major types of stem cells: adult and embryonic. Embryonic stem (ES) cells seem to possess a much higher therapeutic potential, due […]

Fourth Industrial RevolutionWorld
22 May 2018

Fourth Industrial Revolution or Industry 4.0

Insights by José Santacroce, Head of Patent Department at Moeller IP Right now we are experiencing the fourth industrial revolution, the so-called “Industry 4.0”. The first three industrial revolutions were powered by steam, electricity and electronics, respectively. Industry 4.0 is characterized by the combined effects of massive data volumes (big data), powerful computer processing, computers […]

New guidelines clarify divisional filingsChile
21 May 2018

New guidelines clarify divisional filings

By Marta Garcia On November 2017, the Chilean PTO (INAPI) published an update of the patent examination guidelines providing clarifications regarding divisional applications. The Regulations to the Chilean IP Law establish that an applicant may voluntarily divide his/her application into two or more divisional applications until the issuance of the first office action regarding substantive […]

Chemical Patent Applicationsip articles
18 May 2018

INPI Brazil Issues New Guidelines For Chemical Patent Applications

By Moeller IP Advisors According to data from the Chemical Abstract Service (CAS), a division of the American Chemical Society, the number of patents related to chemical products has grown tremendously in the last 20 years: the CAS Registry collects data on more than 132 million organic and inorganic substances. Brazil makes no exception to […]

counterfeit medicines in peruip articles
17 May 2018

The market of Counterfeit Medicines in Peru and the Legal tools to Combat it

By Moeller IP Advisors The market of counterfeit pharmaceuticals is probably the largest among all counterfeit goods, ranging from US$163 billion to $217 billion per year. Counterfeit medicines can include products with the wrong ingredients, without active ingredients, with insufficient active ingredients or with fake packaging. Peru is one of the main markets for counterfeit […]

Draft IP Law reduces terms for patent proceedingsBrazil
16 May 2018

Draft IP Law reduces terms for patent proceedings

By Marta Garcia Last year, Brazilian Senator Cássio Cunha Lima wrote a draft law amending the IP Law in order to reduce the terms for patent proceedings. According to the draft law, patent terms would be amended as follows: a) The term a patent application is kept confidential before publication would be reduced from 18 […]

Medical patent prior examination fast trackingBrazil
15 May 2018

Exame Prioritário de Patentes Médicas – Nova Resolução para o Instituto Brasileiro de Marcas e Parentes

de Moeller IP Brazil Em 08 de maio de 2018 o INPI publicou a resolução n.º 218, alterando a Resolução n. 80 de 19 de março de 2013, regulamentando a prioridade de exame técnico para os pedidos de patente de produtos e processos farmacêuticos, bem como de equipamentos relacionados à saúde publica. Por essa resolução, […]

Medical patent prior examination fast trackingBrazil
15 May 2018

Medical patent prior examination fast tracking – new resolution from the Brazilian Patent and Trademark Office

by Moeller IP Brazil On May 8, 2018, the Brazilian Patent and Trademark Office (INPI) published Resolution No. 218, which amends Resolution number 80 of March 19, 2013.  This regulation prioritizes the technical examination of patent applications for pharmaceutical products and processes, as well as equipment related to public health. Through this resolution, patent applications […]

Moeller IP Advisors

Moeller IP